Our 3 Favourite Picks For 2021 That Insiders Bought Heavily
Insider Ownership, Undervalued growth, Leading businesses, Outperforming stocks
Seeking Alpha Analyst Since 2017
Voor Nederlandstalige beleggers - bezoek beleggersuniversity.com als je wil uitgroeien tot een succesvolle belegger
Founder of Insider Opportunities / A new way of investing (insiders+algos) with 43.6% annualized returns since 2010 / Made hundreds of investors successful and confident in this challenging market environment
During my Master of Business Administration at the University of Ghent (Belgium), I got passionated by finance. When writing my master's thesis I got attracted by the under-appreciated power of the insider investment strategy.
The theory is simple: by following insider (CEOs, CFOs, board members...) purchases, well-respected researchers have proven that you can outperform the market significantly. That's because this "smart money" knows better than anyone else when their stock is undervalued.
But adopting it in your investment practices is not easy: there are 850 purchases reported by the SEC each month, off which only a small fraction is valuable to follow up. As I enjoy challenges, I decided to dedicate my life into building a strategy around this very promising theory.
After years of empirical research, I discovered a revolutionary strategy based on insiders and algorithms which generated 47.2% annual returns since 2010 (3x the S&P 500). My IO Golden Value, Growth and Biotech algorithms pick out the winning insider purchases (on average 6 per month) based on fundamentals and valuations.
I understood this unique strategy could be extremely valuable to investors like you, enhancing returns and strengthening one's confidence in the market. To start improving investors' wealth generation, I decided to find Insider Opportunities in 2020.
Click here to discover Insider Opportunities 14 days for FREE.
By joining our community, you'll have an edge compared to other investors to find undiscovered, undervalued stocks. You'll get exclusive access to our daily Insider at Breakfast articles, outperforming portfolios, weekly market updates, group chat with other investors, and much more.
I'm always happy to talk with other like-minded investors and help them out. Don't hesitate to contact me any time!
Yours sincerely, Robbe
Summary
- We just released our "Insider Guide to Successful investing in 2021" for members which discusses the market and our 10 favourite stocks. We provide 3 of them in this post.
- First, we have an undervalued technology stock growing at 40% and valued at 12x our expected free cash flow, with several catalysts in 2021 - 35% upside.
- Second, we discuss an undervalued, strongly growing staffing business valued at forward P/E of 11.5x which will benefit from the Covid vaccines - 59% upside.
- Last, we provide a company that discovered an anti-ageing pill which will reach the mass market in 2021 at only 4x fwd EV/sales and with 25% revenue growth -312% upside.
GRAB YOUR DEAL HERE!
Overhyped growth stocks are reaching dot-com bubble levels, while most value stocks' undervaluation disappeared after their massive run at the end of 2020.
Consequently, it is getting extremely challenging to find stocks to buy in 2021 which will generate you strong wealth in the future.
Your timing couldn't be better to discover Insider Opportunities! Our investment service provides investors like you undiscovered stocks which are still undervalued via its unique insider strategy.
Dozens of investors like you recently decided to join and are getting a lot of value from their subscription during this uncertain, overvalued market environment.
Especially for you, we started a 2021 Kick-Off Deal to try it out as well! On top of the 15% discount, you will be welcomed with an exclusive report "Insider Guide to Successful Investing in 2021" which includes our 10 favourite picks for 2021.
Lock in your 2021 Kick-Off Deal HERE! Trying it out costs nothing with our 14-day FREE trial!
----------------------------------------------------------------------------------------
Below, I will provide you 3 of our 10 favourite picks discussed in our recently published Insider Guide to Successful Investing in 2021.
All stocks have three things in common: they saw significant insider purchasing activity recently, are undiscovered by the market and are significantly undervalued compared to their fundamentals.
1. Liberated Syndication (OTCPK:LSYN) - $7 target (35% upside)
Undiscovered technology stock growing at 40% and valued at 12x our expected free cash flow, with several catalysts in 2021.
(Source: Insider Opportunities with Tradingview)
(We recommended LSYN in our blog post on December 5 following new insider purchases. The stock is up 26% since this post and up 45% in our Insider Opportunities portfolio, but we see much more upside for 2021.)
Description - Liberated Syndication, founded in 2015 as spin-off, owns the leading podcast hosting platform Libsyn and a web hosting platform Pairs, which are both SaaS-based.
Investment case - LSYN has been undervalued for a very long time as it has been undiscovered as micro cap on the OTC market. 2021 has several big catalysts for the stock. First, an expected uplisting to the Nasdaq would lead to increasing demand for the stock from new investors. Second, their new Libsyn platform will be introduced in 2021 which will accelerate growth. The strong undervaluation, high growth, significant insider activity and catalysts for 2021 make this stock a strong buy.
Financials -
(Source: Insider Opportunities with Tradingview)
2. BG Staffing (BGSF) - $22 target (59% upside)
Undervalued, strongly growing staffing business valued at forward P/E of 11.5x which will benefit from the Covid vaccines.
(Source: Insider Opportunities with Tradingview)
Description - BG Staffing, founded in 2007 and publicly listed since 2014, is a small cap US staffing company which operates through three segments: Real Estate, Professional (accounting, IT etc.), and Light Industrial. In real estate it has a leading position.
Investment case - BG Staffing is valued like a declining commodity staffing business, while it actually is a high-growth, high-margin staffing business. When the pandemic eases in 2021, we expect the market to rediscover this great stock at bargain prices.
Financials -
(Source: Insider Opportunities with Tradingview)
3. Chromadex (CDXC) - $20.54 target (312% upside)
Company which discovered an anti-ageing pill which will reach the mass market in 2021 at only 4x fwd EV/sales and with 25% revenue growth.
(Source: Insider Opportunities with Tradingview)
Description - Chromadex, founded in 1999, is a health supplement company. The company has a patent on TRU Niagen since 2012, a supplement which boosts NAD, reducing the impact of ageing on our body.
Investment case - We believe 2021 could be the break-through year for TRU Niagen. Over the past years, the company has been focusing on studies to prove the impact of TRU Niagen. In 2021 they will accelerate marketing efforts for this anti-ageing product.
Financials -
(Source: Insider Opportunities with Tradingview)
----------------------------------------------------------------------------------------
Read our in-depth reviews of these stocks, find out about our other 7 favourites and be updated daily on the best insider purchases by starting a membership at Insider Opportunities!
Receive our 2021 Kick-Off Deal by clicking HERE and get started with a 14-day FREE TRIAL!
You will be happy after taking this opportunity, just like Eric and Bart, two of our members who have become very successful since becoming member of Insider Opportunities:
---------------------------------------------------------------------------------------
For informative purposes, here are the 2020 returns for our three portfolios which pick out the winning stocks that insiders purchased via a proven algorithm:
Analyst's Disclosure: I am/we are long BGSF, CDXC.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.